<!--?xml version="1.0" encoding="utf-8"?--><!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="plosone"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC4364783/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Aspartame Sensitivity? A Double Blind Randomised Crossover Study</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364783/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="PLoS ONE"><meta name="citation_title" content="Aspartame Sensitivity? A Double Blind Randomised Crossover Study"><meta name="citation_authors" content="Thozhukat Sathyapalan, Natalie J. Thatcher, Richard Hammersley, Alan S. Rigby, Alexandros Pechlivanis, Nigel J. Gooderham, Elaine Holmes, Carel W. le Roux, Stephen L. Atkin, Fraser Courts"><meta name="citation_date" content="2015"><meta name="citation_issue" content="3"><meta name="citation_volume" content="10"><meta name="citation_doi" content="10.1371/journal.pone.0116212"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4364783/?report=abstract"><meta name="citation_pmid" content="25786106"><meta name="DC.Title" content="Aspartame Sensitivity? A Double Blind Randomised Crossover Study"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Public Library of Science"><meta name="DC.Contributor" content="Thozhukat Sathyapalan"><meta name="DC.Contributor" content="Natalie J. Thatcher"><meta name="DC.Contributor" content="Richard Hammersley"><meta name="DC.Contributor" content="Alan S. Rigby"><meta name="DC.Contributor" content="Alexandros Pechlivanis"><meta name="DC.Contributor" content="Nigel J. Gooderham"><meta name="DC.Contributor" content="Elaine Holmes"><meta name="DC.Contributor" content="Carel W. le Roux"><meta name="DC.Contributor" content="Stephen L. Atkin"><meta name="DC.Contributor" content="Fraser Courts"><meta name="DC.Date" content="2015"><meta name="DC.Identifier" content="10.1371/journal.pone.0116212"><meta name="DC.Language" content="en"><meta property="og:title" content="Aspartame Sensitivity? A Double Blind Randomised Crossover Study"><meta property="og:type" content="article"><meta property="og:description" content="Aspartame is a commonly used intense artificial sweetener, being approximately 200 times sweeter than sucrose. There have been concerns over aspartame since approval in the 1980s including a large anecdotal database reporting severe symptoms. The objective ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364783/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plosone.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC4364783/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC4364783/pdf/pone.0116212.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="8A1B7E65E8E3E9810000000004AC04AC.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.ncbi-alerts { background: none repeat scroll 0% 0% #671414;color: #fff;padding: .231em 1.231em;}.ncbi-alerts p { color: #fff; }.ncbi-alerts a, .ncbi-alerts a:visited {color: #fff; background: none;}.ncbi-alerts p {margin: 1em 0;padding: 0 0 0 1.5em; }.ncbi-alerts p:nth-child(1) {background-image: url('/core/icons/information.png');background-position: left top;background-repeat: no-repeat }.ncbi-alerts.subclosed p:nth-child(1) {background-image: url('/core/alerts/warning.png');}.ncbi-alerts.subclosed p { padding-left: 2em;}.ncbi-alerts.pubmed, .ncbi-alerts.pubmed p {background-color: #97B0C8; color: #000;}.ncbi-alerts a { text-decoration: underline !important; }.ncbi-alerts.pubmed a, .ncbi-alerts.pubmed a:visited { color: #000; }.ncbi-alerts, .ncbi-alerts p {background-color: #97B0C8; color: #000;}.ncbi-alerts a, .ncbi-alerts a:visited { color: #000; }</style></head>
    <body class="article" id="ui-ncbiexternallink-4">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	&lt;p class="nojs"&gt;
	&lt;strong&gt;Warning:&lt;/strong&gt;
	The NCBI web site requires JavaScript to function. 
	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;more...&lt;/a&gt;
	&lt;/p&gt;
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4364783%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header" style="margin-bottom: 0px;">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/440/">PLoS One</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/250028/">v.10(3); 2015</a></li><li class="accid">PMC4364783</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plosone.gif" alt="Logo of plosone" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS One" title="PLoS One" href="http://www.plosone.org/" ref="reftype=publisher&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.pone.0116212" ref="reftype=publisher&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext"><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plosone.org/static/checklist.action" ref="reftype=publisher&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plosone.org/static/contact.action" ref="reftype=publisher&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org/" ref="reftype=publisher&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">PLoS One</a></span>. 2015; 10(3): e0116212. </span></div><div><span class="fm-vol-iss-date">Published online 2015 Mar 18. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1371%2Fjournal.pone.0116212" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0116212</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4364783</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/25786106">25786106</a></div></div></div></div><h1 class="content-title">Aspartame Sensitivity? A Double Blind Randomised Crossover Study</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Sathyapalan%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106" class="affpopup" co-rid="_co_idm140572976301344" co-class="co-affbox">Thozhukat Sathyapalan</a>,<sup>
1
,</sup><sup>*</sup> <a href="/pubmed/?term=Thatcher%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106" class="affpopup" co-rid="_co_idm140572975806720" co-class="co-affbox">Natalie J. Thatcher</a>,<sup>
2
,</sup><sup>
¤
</sup> <a href="/pubmed/?term=Hammersley%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106" class="affpopup" co-rid="_co_idm140572982730400" co-class="co-affbox">Richard Hammersley</a>,<sup>
3
</sup> <a href="/pubmed/?term=Rigby%20AS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106" class="affpopup" co-rid="_co_idm140572982728032" co-class="co-affbox">Alan S. Rigby</a>,<sup>
4
</sup> <a href="/pubmed/?term=Pechlivanis%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106" class="affpopup" co-rid="_co_idm140572983039776" co-class="co-affbox">Alexandros Pechlivanis</a>,<sup>
5
</sup> <a href="/pubmed/?term=Gooderham%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106" class="affpopup" co-rid="_co_idm140572983037408" co-class="co-affbox">Nigel J. Gooderham</a>,<sup>
5
</sup> <a href="/pubmed/?term=Holmes%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106" class="affpopup" co-rid="_co_idm140572973080688" co-class="co-affbox">Elaine Holmes</a>,<sup>
5
</sup> <a href="/pubmed/?term=le%20Roux%20CW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106" class="affpopup" co-rid="_co_idm140572973078320" co-class="co-affbox">Carel W. le Roux</a>,<sup>
6
</sup> <a href="/pubmed/?term=Atkin%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106" class="affpopup" co-rid="_co_idm140572981036880" co-class="co-affbox">Stephen L. Atkin</a>,<sup>
7
</sup> and  <a href="/pubmed/?term=Courts%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106" class="affpopup" co-rid="_co_idm140572981034512" co-class="co-affbox">Fraser Courts</a><sup>
8
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140572976301344"><h3 class="no_margin">Thozhukat Sathyapalan</h3><p>  <sup>1</sup>  Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, University of Hull, Hull, United Kingdom,   </p><div>Find articles by <a href="/pubmed/?term=Sathyapalan%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106">Thozhukat Sathyapalan</a></div></div><div id="_co_idm140572975806720"><h3 class="no_margin">Natalie J. Thatcher</h3><p>  <sup>2</sup>  Food Standards Agency, London, United Kingdom,   </p><div>Find articles by <a href="/pubmed/?term=Thatcher%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106">Natalie J. Thatcher</a></div></div><div id="_co_idm140572982730400"><h3 class="no_margin">Richard Hammersley</h3><p>  <sup>3</sup>  Department of Psychology, University of Hull, Hull, United Kingdom,   </p><div>Find articles by <a href="/pubmed/?term=Hammersley%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106">Richard Hammersley</a></div></div><div id="_co_idm140572982728032"><h3 class="no_margin">Alan S. Rigby</h3><p>  <sup>4</sup>  Department of Academic Cardiology, University of Hull, Hull, United Kingdom,   </p><div>Find articles by <a href="/pubmed/?term=Rigby%20AS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106">Alan S. Rigby</a></div></div><div id="_co_idm140572983039776"><h3 class="no_margin">Alexandros Pechlivanis</h3><p>  <sup>5</sup>  Faculty of Medicine, Imperial College, London, United Kingdom,   </p><div>Find articles by <a href="/pubmed/?term=Pechlivanis%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106">Alexandros Pechlivanis</a></div></div><div id="_co_idm140572983037408"><h3 class="no_margin">Nigel J. Gooderham</h3><p>  <sup>5</sup>  Faculty of Medicine, Imperial College, London, United Kingdom,   </p><div>Find articles by <a href="/pubmed/?term=Gooderham%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106">Nigel J. Gooderham</a></div></div><div id="_co_idm140572973080688"><h3 class="no_margin">Elaine Holmes</h3><p>  <sup>5</sup>  Faculty of Medicine, Imperial College, London, United Kingdom,   </p><div>Find articles by <a href="/pubmed/?term=Holmes%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106">Elaine Holmes</a></div></div><div id="_co_idm140572973078320"><h3 class="no_margin">Carel W. le Roux</h3><p>  <sup>6</sup>  Diabetes Complications Research Centre, Conway Institute, University College Dublin, Belfield, Ireland,   </p><div>Find articles by <a href="/pubmed/?term=le%20Roux%20CW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106">Carel W. le Roux</a></div></div><div id="_co_idm140572981036880"><h3 class="no_margin">Stephen L. Atkin</h3><p>  <sup>7</sup>  Weill Cornell Medical College Qatar, Education City PO Box 24144, Doha, Qatar,   </p><div>Find articles by <a href="/pubmed/?term=Atkin%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106">Stephen L. Atkin</a></div></div><div id="_co_idm140572981034512"><h3 class="no_margin">Fraser Courts</h3><p>  <sup>8</sup>  Institute of Food Research, Norwich Research Park, Norwich, Norfolk NR4 7UA, United Kingdom,   </p><div>Find articles by <a href="/pubmed/?term=Courts%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25786106">Fraser Courts</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Heiner K. Berthold, <span class="fm-role">Academic Editor</span><sup></sup></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140572977391936_ai idm140572976301472_ai idm140572983271616_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140572977391936_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140572977391936_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140572977391936_ai" style="display:none"><div class="fm-affl" lang="en" id="aff001">  <sup>1</sup>  Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, University of Hull, Hull, United Kingdom,   </div><div class="fm-affl" lang="en" id="aff002">  <sup>2</sup>  Food Standards Agency, London, United Kingdom,   </div><div class="fm-affl" lang="en" id="aff003">  <sup>3</sup>  Department of Psychology, University of Hull, Hull, United Kingdom,   </div><div class="fm-affl" lang="en" id="aff004">  <sup>4</sup>  Department of Academic Cardiology, University of Hull, Hull, United Kingdom,   </div><div class="fm-affl" lang="en" id="aff005">  <sup>5</sup>  Faculty of Medicine, Imperial College, London, United Kingdom,   </div><div class="fm-affl" lang="en" id="aff006">  <sup>6</sup>  Diabetes Complications Research Centre, Conway Institute, University College Dublin, Belfield, Ireland,   </div><div class="fm-affl" lang="en" id="aff007">  <sup>7</sup>  Weill Cornell Medical College Qatar, Education City PO Box 24144, Doha, Qatar,   </div><div class="fm-affl" lang="en" id="aff008">  <sup>8</sup>  Institute of Food Research, Norwich Research Park, Norwich, Norfolk NR4 7UA, United Kingdom,   </div><div class="fm-affl" lang="en" id="edit1">  Bielefeld Evangelical Hospital, GERMANY,   </div><div id="coi001"><strong>Competing Interests: </strong>Co-author Prof. S.L. Atkin is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to PLOS ONE Editorial policies and criteria. All other authors have no competing interests to declare.</div><div><p id="__p2" class="p p-first-last">Conceived and designed the experiments: SLA NT TS. Performed the experiments: NT TS SLA AP NG CLR FC. Analyzed the data: EH ASR NT TS AP RH CLR. Contributed reagents/materials/analysis tools: NG AP SLA EH CLR TS FC. Wrote the paper: NT TS SLA RH NG CLR ASR AP.</p></div><div id="currentaff001"><sup>¤</sup>Current address: European Food Safety Authority, Parma, Italy</div><div id="cor001">* E-mail: <a href="mailto:dev@null" data-email="ku.ca.smyh@nalapayhtas.takuhzohT" class="oemail">ku.ca.smyh@nalapayhtas.takuhzohT</a></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140572977391936_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2014 Jun 16; Accepted 2014 Nov 25.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140572977391936_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> © 2015 Sathyapalan et al</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div><strong>This article has been corrected. </strong>See <a href="/pmc/articles/PMC4423991/">PLoS One. 2015 May 7; 10(5): e0126039</a>.</div><div style="border-top: 1px solid rgb(102, 102, 153); margin: 5px 10% 3px;"></div><div>This article has been <a href="/pmc/articles/PMC4364783/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="2" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>S1 CONSORT Checklist: </strong>CONSORT checklist. (DOC)</div><div><a href="/pmc/articles/PMC4364783/bin/pone.0116212.s001.doc" data-ga-action="click_feat_suppl">pone.0116212.s001.doc</a><span style="color:gray"> (217K)</span></div><div class="small guid">GUID:&nbsp;61387B40-6321-4961-8733-A00A6F5BDC6F</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>S1 Protocol: </strong>Trial Protocol. (DOC)</div><div><a href="/pmc/articles/PMC4364783/bin/pone.0116212.s002.doc" data-ga-action="click_feat_suppl">pone.0116212.s002.doc</a><span style="color:gray"> (93K)</span></div><div class="small guid">GUID:&nbsp;75F32F2F-2A92-41A5-A44E-90DB386C4606</div></div></dd></dl><dl data-length="76" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p>All relevant data are within the paper and its Supporting Information files.</p></dd></dl></div><div id="idm140572980798112" lang="en" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140572980798112title">Abstract</h2><!--article-meta--><div><div id="sec001" class="sec sec-first"><h3 id="sec001title">Background</h3><p id="__p4" class="p p-first-last">Aspartame is a commonly used intense artificial sweetener, being approximately 200 times sweeter than sucrose. There have been concerns over aspartame since approval in the 1980s including a large anecdotal database reporting severe symptoms. The objective of this study was to compare the acute symptom effects of aspartame to a control preparation.</p></div><div id="sec002" class="sec"><h3 id="sec002title">Methods</h3><p id="__p5" class="p p-first-last">This was a double-blind randomized cross over study conducted in a clinical research unit in United Kingdom. Forty-eight individual who has self reported sensitivity to aspartame were compared to 48 age and gender matched aspartame non-sensitive individuals. They were given aspartame (100mg)-containing or control snack bars randomly at least 7 days apart. The main outcome measures were acute effects of aspartame measured using repeated ratings of 14 symptoms, biochemistry and metabonomics.</p></div><div id="sec003" class="sec"><h3 id="sec003title">Results</h3><p id="__p6" class="p p-first-last">Aspartame sensitive and non-sensitive participants differed psychologically at baseline in handling feelings and perceived stress. Sensitive participants had higher triglycerides (2.05 ± 1.44 vs. 1.26 ± 0.84mmol/L; p value 0.008) and lower HDL-C (1.16 ± 0.34 vs. 1.35 ± 0.54 mmol/L; p value 0.04), reflected in <sup>1</sup>H NMR serum analysis that showed differences in the baseline lipid content between the two groups. Urine metabonomic studies showed no significant differences. None of the rated symptoms differed between aspartame and control bars, or between sensitive and control participants. However, aspartame sensitive participants rated more symptoms particularly in the first test session, whether this was placebo or control. Aspartame and control bars affected GLP-1, GIP, tyrosine and phenylalanine levels equally in both aspartame sensitive and non-sensitive subjects.</p></div><div id="sec004" class="sec"><h3 id="sec004title">Conclusion</h3><p id="__p7" class="p p-first-last">Using a comprehensive battery of psychological tests, biochemistry and state of the art metabonomics there was no evidence of any acute adverse responses to aspartame. This independent study gives reassurance to both regulatory bodies and the public that acute ingestion of aspartame does not have any detectable psychological or metabolic effects in humans.</p></div><div id="sec005" class="sec sec-last"><h3 id="sec005title">Trial Registration</h3><p id="__p8" class="p p-first-last">ISRCTN Registry <a href="http://www.isrctn.com/ISRCTN39650237" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">ISRCTN39650237</a>
</p></div></div></div><div id="sec006" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec006title">Introduction</h2><p id="__p10" class="p p-first">Aspartame (L-aspartic acid and L-phenylalanine bonded as a methyl ester) is an intense artificial sweetener, being approximately 200 times sweeter than sucrose. It is classified as a non-nutritive sweetener due to its intense sweetness and the need for very small amounts to sweeten foods. First approved by the U.S Food and Drug Administration (FDA)[<a href="#pone.0116212.ref001" rid="pone.0116212.ref001" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">1</a>] aspartame is widely used throughout the food and drinks industry; approximately 2000 tonnes are consumed annually in Europe alone[<a href="#pone.0116212.ref002" rid="pone.0116212.ref002" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701136" role="button" aria-expanded="false" aria-haspopup="true">2</a>].</p><p id="__p11">However, controversy over the safety of aspartame has existed since its approval in the 1980s. There are numerous individuals and website organisations promoting a huge volume of anecdotal literature detailing consumer concerns[<a href="#pone.0116212.ref003" rid="pone.0116212.ref003" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_695073016" role="button" aria-expanded="false" aria-haspopup="true">3</a>] that include cancer, multiple sclerosis, blindness, seizures, memory loss, depression, anxiety, obesity, birth defects and death, with anxieties regarding both acute and chronic exposure[<a href="#pone.0116212.ref002" rid="pone.0116212.ref002" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701131" role="button" aria-expanded="false" aria-haspopup="true">2</a>,<a href="#pone.0116212.ref004" rid="pone.0116212.ref004" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701135" role="button" aria-expanded="false" aria-haspopup="true">4</a>–<a href="#pone.0116212.ref008" rid="pone.0116212.ref008" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701143" role="button" aria-expanded="false" aria-haspopup="true">8</a>]. However, this is not supported in the scientific literature. Limited studies on symptoms exist; one study in 13 psychiatric patients suggested increased depression[<a href="#pone.0116212.ref007" rid="pone.0116212.ref007" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701140" role="button" aria-expanded="false" aria-haspopup="true">7</a>], interpretation of studies on headaches is restricted by low numbers of participant and poor study design[<a href="#pone.0116212.ref006" rid="pone.0116212.ref006" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701137" role="button" aria-expanded="false" aria-haspopup="true">6</a>,<a href="#pone.0116212.ref008" rid="pone.0116212.ref008" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701144" role="button" aria-expanded="false" aria-haspopup="true">8</a>–<a href="#pone.0116212.ref011" rid="pone.0116212.ref011" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701149" role="button" aria-expanded="false" aria-haspopup="true">11</a>]. The weight of evidence from these studies suggests no effect on behavior and cognition [<a href="#pone.0116212.ref012" rid="pone.0116212.ref012" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701148" role="button" aria-expanded="false" aria-haspopup="true">12</a>–<a href="#pone.0116212.ref018" rid="pone.0116212.ref018" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701134" role="button" aria-expanded="false" aria-haspopup="true">18</a>].</p><p id="__p12">Consumer apprehension led to a European Food Safety Authority (EFSA) review of aspartame[<a href="#pone.0116212.ref019" rid="pone.0116212.ref019" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">19</a>] including the compilation of a database of the most commonly reported symptoms associated with aspartame consumption[<a href="#pone.0116212.ref020" rid="pone.0116212.ref020" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701139" role="button" aria-expanded="false" aria-haspopup="true">20</a>–<a href="#pone.0116212.ref023" rid="pone.0116212.ref023" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">23</a>]. A metabolic basis for these symptoms was considered but few studies exist: in a study in patients with type 2 diabetes plasma glucose and insulin levels fell similarly for sucrose and aspartame sweetened meals even though calorifically they were different [<a href="#pone.0116212.ref024" rid="pone.0116212.ref024" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701145" role="button" aria-expanded="false" aria-haspopup="true">24</a>].</p><p id="__p13" class="p p-last">In a 2010 review EFSA’s National Experts[<a href="#pone.0116212.ref025" rid="pone.0116212.ref025" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">25</a>] reaffirmed aspartame safety but recognised the need to determine aspartame related symptoms and their metabolic mechanisms. This randomised double blind controlled crossover study was undertaken in self reported aspartame sensitive individuals and matched control subjects, using tests for psychological behavior complemented with state of the art metabonomics to ascertain if potential acute aspartame related symptoms were reflected in the profile of hundreds of metabolites, as even small changes in nutritional or psychological balance can result in changes in pattern and clustering.</p></div><div id="sec007" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec007title">Study Design</h2><p id="__p14" class="p p-first">The protocol for this trial and supporting CONSORT checklist are available as supporting information; see <a href="#pone.0116212.s001" rid="pone.0116212.s001" class=" supplementary-material">S1 CONSORT Checklist</a> and <a href="#pone.0116212.s002" rid="pone.0116212.s002" class=" supplementary-material">S1 Protocol</a>. The study was approved specifically by the East Yorkshire &amp; North Lincolnshire Research Ethics Committee (ref: 09/H1304/46; 30 June 2009). The participants provided informed written consent to participate in this study. The above ethics committee has approved the above consent process.</p><p id="__p15">In this single-centre double blind crossover study individuals self-reporting aspartame sensitivity (AS) (n = 48) were compared to age and gender matched non-sensitive (NS) participants (n = 48) recruited by media advertisement (press advertisements, television and radio). Individuals volunteering were classified as “self reported aspartame sensitive” individuals if they reported suffering one or more symptoms on multiple occasions and as a consequence were actively avoiding consumption of any aspartame in their diet. Individuals with any allergies other than possible aspartame sensitivity were excluded, as was those taking any over-the-counter or prescription medications during the previous 3 months. The participants were reimbursed travel expenses for attending the study visits. Participants were recruited for a 12 month period from Dec 2012 to Dec 2013.</p><p id="__p16">Aspartame (100mg, equivalent to that consumed in a can of diet soda and less than the Acceptable Daily Intake maximum (ADI) recommended by FDA of 40mg/kg body weight/day) was incorporated into cold pressed cereal bars (Campden BRI, United Kingdom). In a prior taste trial, 40 healthy controls could not distinguish between aspartame or control bars. Randomisation was performed by Campden BRI. The study was unblinded only after all of the analyses had been undertaken.</p><p id="__p17">In a ‘within-between’ design; the independent factors being participant type (sensitive or control) and test (aspartame versus control bar) and a within-subjects factor of test order.</p><p id="__p18">There is little published guidance on sample size for pilot studies. Hertzog found that sample sizes between ranging between10–80 per group met a variety of aims (e.g., problems of data collection strategies, answering methodical queries, estimating variability, planning a larger study). This was irrespective of statistical test. Our choice (48 per group) was at the upper end of this range in line with Hertzog’s recommendations for planning future trials [<a href="#pone.0116212.ref026" rid="pone.0116212.ref026" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701130" role="button" aria-expanded="false" aria-haspopup="true">26</a>].</p><p id="__p19" class="p">In addition 25 participants with self-reported aspartame sensitivity and 25 matched control participants were recruited to look at nocebo effect where they were given two lots of placebo (second part). The nocebo effect refers to the negative consequences of an inert treatment [<a href="#pone.0116212.ref027" rid="pone.0116212.ref027" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701133" role="button" aria-expanded="false" aria-haspopup="true">27</a>]. The intention was to analyse the second part of the study only if any discriminating effect was observed between the two arms in the first part of the study. Since there were no discriminating effect in the first study, the biochemical and psychological part of the second study was not performed.</p><div id="sec008" class="sec"><h3 id="sec008title">Study Procedures</h3><p id="__p20" class="p p-first-last">Following an 8 hour overnight fast participants were given the aspartame or control bar, and crossed over at least 1 week apart. Bars were consumed within 5 minutes. Standard questionnaires were used to assess psychological condition at baseline, and 14 symptoms were rated repeatedly over 4 hours after consuming bars <em>(see section “<a href="#sec010" rid="sec010" class=" sec">psychological data</a>”)</em>. Blood samples were taken at baseline and at 4 hours: urine specimens were provided at baseline, at 4, 12 and 24 hours.</p></div><div id="sec009" class="sec"><h3 id="sec009title">Biochemical analysis</h3><p id="__p21" class="p p-first-last">Fasting venous blood was collected into serum gel, EDTA plasma and fluoride oxalate tubes. Plasma glucose was measured using a Synchron LX 20 analyzer (Beckman-Coulter, High Wycombe, UK). Other samples were separated by centrifugation at 2000 g for 15 min at 4°C, and aliquots stored at −80°C. Total cholesterol, triglycerides and high-density lipoprotein cholesterol (HDL-C) levels were measured enzymatically using a Synchron LX20 analyzer (Beckman-Coulter, High Wycombe, UK). Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald equation. Serum insulin was assayed using a competitive chemiluminescent immunoassay performed on the manufacturer’s DPC Immulite 2000 analyzer (Euro/DPC, Llanberis, UK). The analytical sensitivity of the insulin assay was 2μU/ml, coefficient of variation 6%, and there was no stated cross-reactivity with proinsulin. Insulin resistance was calculated using the homeostasis model assessment (HOMA) method (HOMA-IR = (insulin x glucose)/22.5). Serum CRP was measured by the high-sensitivity method on a Beckman DXC analyser. Incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) were measured using ELISA methods (Linco Research, Missouri, MO, US). Plasma L-Tyr and L-Phe were measured simultaneously by LC-MS. Precision was assessed over 5 determinations of 8 analyte concentrations (1, 5, 10, 50, 100, 200, 300, 400 μM), giving mean deviations of 3.2% and 3.7% for L-Tyr and L-Phe respectively.</p></div><div id="sec010" class="sec"><h3 id="sec010title">Psychological data</h3><p id="__p22" class="p p-first-last">Baseline: Beck Depression Inventory (BDI); Hospital Anxiety and Depression Scale (HADS); Perceived Stress Severity Scale (PSS); life events in the past 12 months (SRRI); Toronto Alexithymia Scale (TAS-20); Whiteley-7 Somatisation Index; State Trait Anxiety Inventory (STAI). After consumption: 14 symptoms were rated ten times during each session (unmarked visual analogue scales 0–100): Headache; mood swings; hot or flushed; nausea; tiredness; dizziness; nasal congestion; visual problems; tingling; bloating; hunger; thirst; happiness; arousal. Fifteen participants did not complete any symptom ratings and they were excluded from the psychological analyses. The 10th set of ratings were discarded as 37 were incomplete. With rated mood and symptom data of this kind there is no theoretical or a priori way of combining symptoms, which makes it necessary to analyse each symptom separately over time, leading to a large number of analyses and increasing the risk of Type 1 error. This was appropriate here, because the study sought any evidence of aspartame symptoms, even if these would not be consequential in the general population. Eight participants left at least one symptom rating blank across an entire test session, these data were kept missing, leading to varying numbers of participants in each symptom analysis. Other missing data were interpolated by replacing the missing value with the highest value from +/- two ratings in time on the same item. Symptom ratings were then summed across the nine ratings, and a total symptom score for nine ratings of 14 items was also calculated.</p></div><div id="sec011" class="sec"><h3 id="sec011title">Metabonomic analysis</h3><p id="__p23" class="p p-first-last">Metabonomic analysis of serum and urine utilised high throughput nuclear magnetic resonance (NMR) spectroscopy, and liquid chromatography coupled to mass spectrometry (UPLC-MS) lipid analysis followed by multivariate chemometric data analysis.</p></div><div id="sec012" class="sec"><h3 id="sec012title">NMR data Acquisition</h3><p id="__p24" class="p p-first">A Bruker Avance III 600 MHz spectrometer (Bruker Analytische GmbH, Rheinstetten, Germany), employing an inverse detection probe of 5 mm width with z-gradients, at 300 K was used.</p><p id="__p25">Urine analysis: 1D NOESY pulse sequence with presaturation (25 Hz) for water signal suppression collecting 128 scans in 64-k data points over a spectral width of 12019.23 Hz, using a relaxation delay of 2 s, an acquisition time of 6.83 s and a mixing time of 0.01 s. Serum samples: Carr-Purcell-Meiboom-Gill (CPMG) utilising a T2 relaxation time filter to suppress the broad lipoprotein signals and presaturation (25 Hz) for water signal suppression, collecting 128 scans in 64-k data points over a spectral width of 7194.2 Hz, using a total delay of 6.55 s between pulse cycles.</p><p id="__p26" class="p p-last">NMR data were visually inspected, imported in Matlab, phased, baseline corrected and referenced to TSP (urine) and glucose (serum) using in-house routines. Probabilistic quotient normalisation was used for both urine and serum. Unsupervised and supervised chemometric analyses were performed utilising SIMCA 13 (Umetrics) software[<a href="#pone.0116212.ref028" rid="pone.0116212.ref028" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701132" role="button" aria-expanded="false" aria-haspopup="true">28</a>]. Analysis was blinded to aspartame consumption and subject group (AS or NS).</p></div><div id="sec013" class="sec"><h3 id="sec013title">LCMS Lipidomics acquisition</h3><p id="__p27" class="p p-first-last">A subset of samples from 12 randomly picked individuals from each coded group, were analysed for lipids in +ESI and -ESI. XCMS peak picking [<a href="#pone.0116212.ref029" rid="pone.0116212.ref029" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701138" role="button" aria-expanded="false" aria-haspopup="true">29</a>], median fold change normalization[<a href="#pone.0116212.ref030" rid="pone.0116212.ref030" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701128" role="button" aria-expanded="false" aria-haspopup="true">30</a>] was performed prior to chemometric analysis in SIMCA 13.</p></div><div id="sec014" class="sec sec-last"><h3 id="sec014title">Statistical analyses</h3><p id="__p28" class="p p-first-last">Normality of the data was determined using the Kolmogorov-Smirnov test. Biochemical and clinical data compared participant types and treatments by independent and paired t-tests as appropriate. Baseline psychological measures were compared between participant types (AS/NS) and session order (aspartame then control or control then aspartame) using multivariate analysis of variance. To reduce the number of analyses, for each symptom ratings after consumption were summed across four hours to give a composite score on each symptom for each test session out of 900, plus a sum of all symptom ratings. Before analysis of variance, all composite scores were log transformed to increase normality of their frequency distributions. Composite scores were then analysed by 15 repeated measures analyses of variance with session (first or second) as a repeated measures variable, and type of participant (AS/NS) and order of test as independent factors. In this design effects of aspartame would appear as a significant interaction between session and order, and significant effects of sensitivity by an interaction between session, order and type. Post-hoc comparisons for variables where there were significant effects were conducted using Mann-Whitney U tests. For all analyses, a two-tailed P ≤0.05 was considered to indicate statistical significance, correcting for 15 multiple comparisons would have given p&lt;0.0033. For brevity, only significant and marginal results where p&lt;0.06 are reported. All omitted effects were non-significant.</p></div></div><div id="sec015" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec015title">Results</h2><div id="sec016" class="sec sec-first"><h3 id="sec016title">Characteristics of the participants</h3><p id="__p29" class="p p-first">Although 268 self-reported aspartame sensitive individuals (AS) inquired, only 53 (21 men, 32 women) attended and gave their informed consent to take part in the study, with only 48 completing both sessions. Participants were matched by age and sex to 49 aspartame non-sensitive (NS) individuals (23 men, 26 women) (<a href="/pmc/articles/PMC4364783/table/pone.0116212.t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone.0116212.t001" rid-ob="ob-pone.0116212.t001" co-legend-rid=""><span>Table 1</span></a>). Two participants (1 man, age 65 and 1 woman, age 70 years) from the aspartame sensitive group and one non-sensitive participant (1 man, age 41 years) dropped out due to changes in personal circumstances. One man was excluded because of a self-limiting gastro-intestinal upset during one session (revealed when unblinded to be after control). Consort diagram is given in <a href="/pmc/articles/PMC4364783/figure/pone.0116212.g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0116212.g001" rid-ob="ob-pone.0116212.g001" co-legend-rid="lgnd_pone.0116212.g001"><span>Fig. 1</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone.0116212.g001" co-legend-rid="lgnd_pone.0116212.g001"><a href="/pmc/articles/PMC4364783/figure/pone.0116212.g001/" target="figure" rid-figpopup="pone.0116212.g001" rid-ob="ob-pone.0116212.g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140572982157024" class="figure"><a href="/pmc/articles/PMC4364783/figure/pone.0116212.g001/" target="figure" rid-figpopup="pone.0116212.g001" rid-ob="ob-pone.0116212.g001"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4364783_pone.0116212.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is pone.0116212.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4364783/bin/pone.0116212.g001.jpg"></a></div><div id="largeobj_idm140572982157024" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC4364783/figure/pone.0116212.g001/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_pone.0116212.g001"><div><a class="figpopup" href="/pmc/articles/PMC4364783/figure/pone.0116212.g001/" target="figure" rid-figpopup="pone.0116212.g001" rid-ob="ob-pone.0116212.g001">Fig 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Consort diagram.</strong></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone.0116212.t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Baseline parameters before aspartame and placebo preparation in aspartame sensitive and control groups.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140572973821040" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="left" rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1"></th></tr><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="left" rowspan="1" colspan="1">Sensitive</th><th align="left" rowspan="1" colspan="1">Controls</th><th align="left" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1">50.53 ± 16.24</td><td align="left" rowspan="1" colspan="1">52.42± 15.38</td><td align="left" rowspan="1" colspan="1">0.56</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="left" rowspan="1" colspan="1">88.28 ± 17.30</td><td align="left" rowspan="1" colspan="1">83.13 ± 20.34</td><td align="left" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index (kg/ m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">30.14± 5.71</td><td align="left" rowspan="1" colspan="1">28.87 ± 5.9</td><td align="left" rowspan="1" colspan="1">0.29</td></tr><tr><td align="left" rowspan="1" colspan="1">Waist (cm)</td><td align="left" rowspan="1" colspan="1">97.03 ± 2.20</td><td align="left" rowspan="1" colspan="1">93.23 ± 2.57</td><td align="left" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" rowspan="1" colspan="1">Hip (cm)</td><td align="left" rowspan="1" colspan="1">106.27± 14.77</td><td align="left" rowspan="1" colspan="1">103.15 ±17.61</td><td align="left" rowspan="1" colspan="1">0.38</td></tr></tbody></table></div><div id="largeobj_idm140572973821040" class="largeobj-link align_right" style="display: none;"><a target="object" href="/pmc/articles/PMC4364783/table/pone.0116212.t001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="t001fn001"><p id="__p30" class="p p-first-last">Data are means ± standard deviation</p></div></div></div></div><div id="sec017" class="sec"><h3 id="sec017title">Psychological results</h3><p id="__p31" class="p p-first">
<strong>Baseline psychological state (<a href="/pmc/articles/PMC4364783/table/pone.0116212.t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone.0116212.t002" rid-ob="ob-pone.0116212.t002" co-legend-rid=""><span>Table 2</span></a>)</strong>. In MANOVA there were significant differences between sensitive participants and controls on: Perceived stress severity (F(1,43) = 6.13, p = 0.017); TAS identifying feelings (F(1,43) = 5.58, p = 0.023); TAS describing feelings (F(1,43) = 4.28, p = 0.045); TAS total score (F(1,43) = 5.70, p = 0.021). There was also a significant type of participant by order interaction for Perceived Stress Severity (F(1,43) = 5.64, p = 0.022). Preliminary analyses indicated that none of these variables explained variance in symptom rating, so final analyses excluded them.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone.0116212.t002"><h3>Table 2</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Aspartame sensitive and non-sensitive participants' scores on baseline psychological measures.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140572983207024" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Groups</th><th align="left" rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1">Anxiety (HADS)</th><th align="left" rowspan="1" colspan="1">Depression (BDI)</th><th align="left" rowspan="1" colspan="1">Depression (HADS)</th><th align="left" rowspan="1" colspan="1">Perceived Stress Severity</th><th align="left" rowspan="1" colspan="1">Life Events12m</th><th align="left" rowspan="1" colspan="1">Feelings (TAS)</th><th align="left" rowspan="1" colspan="1">Somatisation (Whiteley)</th><th align="left" rowspan="1" colspan="1">State Anxiety</th><th align="left" rowspan="1" colspan="1">Trait Anxiety</th></tr></thead><tbody><tr><td rowspan="3" align="left" colspan="1">Sensitive</td><td align="left" rowspan="1" colspan="1">Mean</td><td align="left" rowspan="1" colspan="1">5.11</td><td align="left" rowspan="1" colspan="1">8.57</td><td align="left" rowspan="1" colspan="1">3.34</td><td align="left" rowspan="1" colspan="1">13.89</td><td align="left" rowspan="1" colspan="1">244.98</td><td align="left" rowspan="1" colspan="1">47.63</td><td align="left" rowspan="1" colspan="1">3.16</td><td align="left" rowspan="1" colspan="1">31.61</td><td align="left" rowspan="1" colspan="1">35.45</td></tr><tr><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">47</td><td align="left" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">47</td><td align="left" rowspan="1" colspan="1">46</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">46</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">41</td><td align="left" rowspan="1" colspan="1">42</td></tr><tr><td align="left" rowspan="1" colspan="1">Std. Deviation</td><td align="left" rowspan="1" colspan="1">3.83</td><td align="left" rowspan="1" colspan="1">7.34</td><td align="left" rowspan="1" colspan="1">3.23</td><td align="left" rowspan="1" colspan="1">6.77</td><td align="left" rowspan="1" colspan="1">281.25</td><td align="left" rowspan="1" colspan="1">12.99</td><td align="left" rowspan="1" colspan="1">3.18</td><td align="left" rowspan="1" colspan="1">11.17</td><td align="left" rowspan="1" colspan="1">10.32</td></tr><tr><td rowspan="3" align="left" colspan="1">Control</td><td align="left" rowspan="1" colspan="1">Mean</td><td align="left" rowspan="1" colspan="1">4.86</td><td align="left" rowspan="1" colspan="1">5.43</td><td align="left" rowspan="1" colspan="1">2.30</td><td align="left" rowspan="1" colspan="1">11.07</td><td align="left" rowspan="1" colspan="1">279.04</td><td align="left" rowspan="1" colspan="1">43.16</td><td align="left" rowspan="1" colspan="1">2.63</td><td align="left" rowspan="1" colspan="1">29.83</td><td align="left" rowspan="1" colspan="1">32.28</td></tr><tr><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">46</td><td align="left" rowspan="1" colspan="1">47</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">41</td><td align="left" rowspan="1" colspan="1">41</td><td align="left" rowspan="1" colspan="1">40</td></tr><tr><td align="left" rowspan="1" colspan="1">Std. Deviation</td><td align="left" rowspan="1" colspan="1">3.74</td><td align="left" rowspan="1" colspan="1">6.40</td><td align="left" rowspan="1" colspan="1">2.46</td><td align="left" rowspan="1" colspan="1">6.00</td><td align="left" rowspan="1" colspan="1">457.95</td><td align="left" rowspan="1" colspan="1">11.60</td><td align="left" rowspan="1" colspan="1">2.57</td><td align="left" rowspan="1" colspan="1">9.53</td><td align="left" rowspan="1" colspan="1">9.80</td></tr><tr><td rowspan="3" align="left" colspan="1">Total</td><td align="left" rowspan="1" colspan="1">Mean</td><td align="left" rowspan="1" colspan="1">4.99</td><td align="left" rowspan="1" colspan="1">6.86</td><td align="left" rowspan="1" colspan="1">2.84</td><td align="left" rowspan="1" colspan="1">12.48</td><td align="left" rowspan="1" colspan="1">261.48</td><td align="left" rowspan="1" colspan="1">45.44</td><td align="left" rowspan="1" colspan="1">2.91</td><td align="left" rowspan="1" colspan="1">30.72</td><td align="left" rowspan="1" colspan="1">33.90</td></tr><tr><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">91</td><td align="left" rowspan="1" colspan="1">81</td><td align="left" rowspan="1" colspan="1">91</td><td align="left" rowspan="1" colspan="1">92</td><td align="left" rowspan="1" colspan="1">97</td><td align="left" rowspan="1" colspan="1">90</td><td align="left" rowspan="1" colspan="1">86</td><td align="left" rowspan="1" colspan="1">82</td><td align="left" rowspan="1" colspan="1">82</td></tr><tr><td align="left" rowspan="1" colspan="1">Std. Deviation</td><td align="left" rowspan="1" colspan="1">3.767</td><td align="left" rowspan="1" colspan="1">6.98</td><td align="left" rowspan="1" colspan="1">2.92</td><td align="left" rowspan="1" colspan="1">6.52</td><td align="left" rowspan="1" colspan="1">375.71</td><td align="left" rowspan="1" colspan="1">12.47</td><td align="left" rowspan="1" colspan="1">2.91</td><td align="left" rowspan="1" colspan="1">10.36</td><td align="left" rowspan="1" colspan="1">10.13</td></tr></tbody></table></div><div id="largeobj_idm140572983207024" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4364783/table/pone.0116212.t002/?report=objectonly">Open in a separate window</a></div></div><p id="__p32">
<strong>Visual analogue symptom scales over 4 hours of the trial</strong>. There were small session by order interactions for: mood swings (F(1,85) = 6.26, p = 0.014); hotness (F(1,84) = 4.49, p = 0.037); arousal (F(1,85) = 5.16, p = 0.026; vision (F(1,85) = 5.62, p = 0.020). There were no session by order by type interactions. Post-hoc Mann Whitney U tests were conducted to compare aspartame and no aspartame bars in each session. There were no significant differences on any symptom. Visual inspection of the data suggested that differences in ANOVA were due to the continued non-normality of the symptom ratings, even after transformation. <a href="/pmc/articles/PMC4364783/figure/pone.0116212.g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0116212.g002" rid-ob="ob-pone.0116212.g002" co-legend-rid="lgnd_pone.0116212.g002"><span>Fig. 2</span></a>, shows box whisker plots for the differences between session one and session two ratings for visual symptoms, illustrating the absence of differences between groups and treatments, and the presence of outliers who rated a lot of symptoms in the sensitive group.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone.0116212.g002" co-legend-rid="lgnd_pone.0116212.g002"><a href="/pmc/articles/PMC4364783/figure/pone.0116212.g002/" target="figure" rid-figpopup="pone.0116212.g002" rid-ob="ob-pone.0116212.g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140572981908144" class="figure"><a href="/pmc/articles/PMC4364783/figure/pone.0116212.g002/" target="figure" rid-figpopup="pone.0116212.g002" rid-ob="ob-pone.0116212.g002"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4364783_pone.0116212.g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is pone.0116212.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4364783/bin/pone.0116212.g002.jpg"></a></div><div id="largeobj_idm140572981908144" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4364783/figure/pone.0116212.g002/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_pone.0116212.g002"><div><a class="figpopup" href="/pmc/articles/PMC4364783/figure/pone.0116212.g002/" target="figure" rid-figpopup="pone.0116212.g002" rid-ob="ob-pone.0116212.g002">Fig 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Differences between ratings of visual symptoms across session one and session two.</strong><p id="__p33">Positive differences indicate that aspartame was rated higher than control. AS = Aspartame sensitive, NS = Non sensitive. It can be seen that there were no differences between groups on ratings, but the aspartame sensitive participants who rated control bars first included three outlier participants more extreme than any in the other groups.</p></div></div></div><p id="__p34" class="p p-last">Main effects of participant type were found on total symptoms (F(1,77) = 10.57, p = 0.002 and nasal congestion (F(1,84) = 4.09, p = 0.046), indicating that sensitive participants tended to rate more symptoms to aspartame and control. Also, type by time interactions for headache (F(1,84) = 8.29, p = 0.014), nausea (F(1,85) = 11.65, p = 0.001), dizziness (F(1,85) = 11.17, p = 0.001), nasal congestion (F(1,84) = 7.14, p = 0.009, tingling (F(1,84) = 7.10, p = 0.009), thirst (F(1,82) = 4.11, p = 0.046), and bloating (F(1,75) = 6.69, p = 0.012), indicating that sensitive participants tended to rate more symptoms during the first test session.</p></div><div id="sec018" class="sec"><h3 id="sec018title">Biochemistry results</h3><p id="__p35" class="p p-first">There were no differences in age (AS 50.5 ± 16.2 v NS 52.4 ± 15.4), weight (AS 88.3 ± 17.3 v NS 83.1 ± 20.3), BMI (AS 30.1 ± 5.7 v NS 28.9 ± 5.9), waist (AS 97.0 ± 2.2 v NS 93.2 ± 2.6), or hip circumference (AS 106.3 ± 14.8 v NS 103.2 ± 17.6), Baseline biochemical parameters were comparable in the AS and NS subjects; however, higher triglycerides (2.05 ± 1.44 vs. 1.26 ± 0.84mmol/L; p value 0.008) and lower HDL-C (1.16 ± 0.34 vs. 1.35 ± 0.54 mmol/L; p value 0.04) were observed in the AS group.</p><p id="__p36" class="p">There was a significant increase in GLP-1 and a reduction in GIP, tyrosine and phenylalanine in both the aspartame sensitive and non-sensitive groups after aspartame and control preparations (<a href="/pmc/articles/PMC4364783/table/pone.0116212.t003/" target="table" class="fig-table-link figpopup" rid-figpopup="pone.0116212.t003" rid-ob="ob-pone.0116212.t003" co-legend-rid=""><span>Table 3</span></a>). The changes in the above parameters were not significantly different between AS and NS groups and aspartame and control preparations.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone.0116212.t003"><h3>Table 3</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Changes in biochemical parameters after aspartame and control preparation in aspartame sensitive and non-sensitive group.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140572984431632" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th colspan="9" align="left" rowspan="1">Parameter</th></tr><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="left" rowspan="1" colspan="1">Sensitive</th><th align="left" rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1">Sensitive</th><th align="left" rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1">Control</th><th align="left" rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1">Control</th><th align="left" rowspan="1" colspan="1"></th></tr><tr><th align="left" rowspan="1" colspan="1">Treatment</th><th align="left" rowspan="1" colspan="1">Pre-aspartame</th><th align="left" rowspan="1" colspan="1">Post-aspartame</th><th align="left" rowspan="1" colspan="1">Pre-control</th><th align="left" rowspan="1" colspan="1">Post-control</th><th align="left" rowspan="1" colspan="1">Pre-aspartame</th><th align="left" rowspan="1" colspan="1">Post-aspartame</th><th align="left" rowspan="1" colspan="1">Pre-control</th><th align="left" rowspan="1" colspan="1">Post-control</th></tr><tr><th align="left" rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1">Mean ± SEM</th><th align="left" rowspan="1" colspan="1">Mean ± SEM</th><th align="left" rowspan="1" colspan="1">Mean ± SEM</th><th align="left" rowspan="1" colspan="1">Mean ± SEM</th><th align="left" rowspan="1" colspan="1">Mean ± SEM</th><th align="left" rowspan="1" colspan="1">Mean ± SEM</th><th align="left" rowspan="1" colspan="1">Mean ± SEM</th><th align="left" rowspan="1" colspan="1">Mean ± SEM</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Glucose (mmol/L)</td><td align="left" rowspan="1" colspan="1">5.70 ± 0.24</td><td align="left" rowspan="1" colspan="1">6.19 ± 0.46</td><td align="left" rowspan="1" colspan="1">5.78 ± 0.31</td><td align="left" rowspan="1" colspan="1">6.32 ± 0.48</td><td align="left" rowspan="1" colspan="1">5.30 ± 0.21</td><td align="left" rowspan="1" colspan="1">5.39 ± 0.22</td><td align="left" rowspan="1" colspan="1">5.32 ± 0.23</td><td align="left" rowspan="1" colspan="1">5.51 ± 0.31</td></tr><tr><td align="left" rowspan="1" colspan="1">Insulin (μIU/mL)</td><td align="left" rowspan="1" colspan="1">15.02 ± 2.03</td><td align="left" rowspan="1" colspan="1">14.89 ± 2.14</td><td align="left" rowspan="1" colspan="1">14.10± 2.07</td><td align="left" rowspan="1" colspan="1">13.30 ± 2.05</td><td align="left" rowspan="1" colspan="1">10.26 ± 1.13</td><td align="left" rowspan="1" colspan="1">9.56 ± 1.23</td><td align="left" rowspan="1" colspan="1">10.74 ± 1.05</td><td align="left" rowspan="1" colspan="1">9.18 ± 1.17</td></tr><tr><td align="left" rowspan="1" colspan="1">HOMA_IR</td><td align="left" rowspan="1" colspan="1">3.70 ± 0.66</td><td align="left" rowspan="1" colspan="1">4.51 ± 1.15</td><td align="left" rowspan="1" colspan="1">3.90± 0.83</td><td align="left" rowspan="1" colspan="1">4.34 ± 1.12</td><td align="left" rowspan="1" colspan="1">2.54 ± 0.39</td><td align="left" rowspan="1" colspan="1">2.51 ± 0.47</td><td align="left" rowspan="1" colspan="1">2.59 ± 0.45</td><td align="left" rowspan="1" colspan="1">2.72 ± 0.65</td></tr><tr><td align="left" rowspan="1" colspan="1">TC (mmol/L)</td><td align="left" rowspan="1" colspan="1">4.79 ± 0.19</td><td align="left" rowspan="1" colspan="1">4.85 ± 0.19</td><td align="left" rowspan="1" colspan="1">4.68 ± 0.18</td><td align="left" rowspan="1" colspan="1">4.76 ± 0.18</td><td align="left" rowspan="1" colspan="1">4.67 ± 0.18</td><td align="left" rowspan="1" colspan="1">4.72 ± 0.18</td><td align="left" rowspan="1" colspan="1">4.65 ± 0.16</td><td align="left" rowspan="1" colspan="1">4.65 ± 0.17</td></tr><tr><td align="left" rowspan="1" colspan="1">Triglycerides (mmol/L)</td><td align="left" rowspan="1" colspan="1">1.98 ± 0.22</td><td align="left" rowspan="1" colspan="1">1.77 ± 0.16</td><td align="left" rowspan="1" colspan="1">1.86 ± 0.18</td><td align="left" rowspan="1" colspan="1">1.77 ± 0.18</td><td align="left" rowspan="1" colspan="1">1.28 ± 0.09</td><td align="left" rowspan="1" colspan="1">1.23 ± 0.09</td><td align="left" rowspan="1" colspan="1">1.25 ± 0.08</td><td align="left" rowspan="1" colspan="1">1.23 ± 0.09</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL-C (mmol/L)</td><td align="left" rowspan="1" colspan="1">2.79 ± 0.16</td><td align="left" rowspan="1" colspan="1">2.87 ± 0.16</td><td align="left" rowspan="1" colspan="1">2.72± 0.15</td><td align="left" rowspan="1" colspan="1">2.76 ± 0.14</td><td align="left" rowspan="1" colspan="1">2.72 ± 0.13</td><td align="left" rowspan="1" colspan="1">2.78 ± 0.12</td><td align="left" rowspan="1" colspan="1">2.73 ± 0.10</td><td align="left" rowspan="1" colspan="1">2.73 ± 0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL-C (mmol/L)</td><td align="left" rowspan="1" colspan="1">1.16 ± 0.05</td><td align="left" rowspan="1" colspan="1">1.20 ± 0.05</td><td align="left" rowspan="1" colspan="1">1.16 ± 0.06</td><td align="left" rowspan="1" colspan="1">1.19 ± 0.06</td><td align="left" rowspan="1" colspan="1">1.35 ± 0.08</td><td align="left" rowspan="1" colspan="1">1.38 ± 0.08</td><td align="left" rowspan="1" colspan="1">1.35 ± 0.07</td><td align="left" rowspan="1" colspan="1">1.35 ± 0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">GLP-1 pM</td><td align="left" rowspan="1" colspan="1">26.66 ± 1.83</td><td align="left" rowspan="1" colspan="1">57.85 ± 10.31<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">30.00 ± 2.09</td><td align="left" rowspan="1" colspan="1">51.16 ± 8.76<sup>*</sup>
</td><td align="left" rowspan="1" colspan="1">25.95 ± 1.38</td><td align="left" rowspan="1" colspan="1">59.67 ± 15.22</td><td align="left" rowspan="1" colspan="1">25.48 ± 1.28</td><td align="left" rowspan="1" colspan="1">45.82 ± 7.06<sup>**</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">GIP pg/mL</td><td align="left" rowspan="1" colspan="1">75.14 ± 3.82</td><td align="left" rowspan="1" colspan="1">48.28 ± 4.15<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">75.95 ± 3.66</td><td align="left" rowspan="1" colspan="1">47.69 ± 3.06<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">77.70 ± 4.19</td><td align="left" rowspan="1" colspan="1">49.19 ± 4.22<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">76.98 ± 4.19</td><td align="left" rowspan="1" colspan="1">42.18 ± 2.77<sup>***</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Tyrosine μM</td><td align="left" rowspan="1" colspan="1">76.04 ± 2.83</td><td align="left" rowspan="1" colspan="1">62.85 ± 2.90<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">74.43 ± 3.09</td><td align="left" rowspan="1" colspan="1">62.20 ± 2.62<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">69.85 ± 2.59</td><td align="left" rowspan="1" colspan="1">58.76 ± 2.23<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">68.09 ± 2.62</td><td align="left" rowspan="1" colspan="1">57.01 ± 2.10<sup>***</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Phenylalanine μM</td><td align="left" rowspan="1" colspan="1">82.01 ± 2.73</td><td align="left" rowspan="1" colspan="1">77.92 ± 2.48<sup>*</sup>
</td><td align="left" rowspan="1" colspan="1">80.74 ± 2.55</td><td align="left" rowspan="1" colspan="1">74.80 ± 2.06<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">76.21 ± 2.00</td><td align="left" rowspan="1" colspan="1">73.63 ± 1.86</td><td align="left" rowspan="1" colspan="1">77.85 ± 1.67</td><td align="left" rowspan="1" colspan="1">72.40 ± 1.87<sup>***</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">TP ratio</td><td align="left" rowspan="1" colspan="1">1.11 ± 0.03</td><td align="left" rowspan="1" colspan="1">1.29 ±0.04 <sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">1.12 ± 0.04</td><td align="left" rowspan="1" colspan="1">1.26 ± 0.05<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">1.13 ± 0.04</td><td align="left" rowspan="1" colspan="1">1.30 ± 0.04<sup>*</sup>
</td><td align="left" rowspan="1" colspan="1">1.19 ± 0.04</td><td align="left" rowspan="1" colspan="1">1.32 ± 0.04<sup>***</sup>
</td></tr></tbody></table></div><div id="largeobj_idm140572984431632" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4364783/table/pone.0116212.t003/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="t003fn001"><p id="__p37" class="p p-first-last">To convert values for glucose to milligrams per deciliter, divide by 0.056.</p></div><div id="t003fn002"><p id="__p38" class="p p-first-last">To convert values for insulin to picomoles per liter, multiply by 6.</p></div><div id="t003fn003"><p id="__p39" class="p p-first-last">To convert values for cholesterol to milligrams per deciliter, divide by 0.0259.</p></div><div id="t003fn004"><p id="__p40" class="p p-first-last">To convert values for triglycerides to milligrams per deciliter, divide by 0.0113.</p></div><div id="t003fn005"><p id="__p41" class="p p-first-last">TC—Total cholesterol; LDL-C—LDL-cholesterol; HDL-C—HDL cholesterol; TG-Triglycerides</p></div><div id="t003fn006"><p id="__p42" class="p p-first-last">GLP-1—Glucagon-like peptide-1</p></div><div id="t003fn007"><p id="__p43" class="p p-first-last">GIP—Glucose-dependent insulinotropic polypeptide</p></div><div id="t003fn008"><p id="__p44" class="p p-first-last">HOMA—Homeostasis model of assessment—insulin resistance</p></div><div id="t003fn009"><p id="__p45" class="p p-first-last">TP ratio—Tyrosine/Phenylalanine ratio</p></div><div id="t003fn010"><p id="__p46" class="p p-first-last">Mean ± SEM—Mean ± Standard error of mean</p></div><div id="t003fn011"><p id="__p47" class="p p-first-last">AP difference—difference between aspartame and control group</p></div><div id="t003fn012"><p id="__p48" class="p p-first-last">P value –</p></div><div id="t003fn013"><p id="__p49" class="p p-first-last">* P &lt; 0.05</p></div><div id="t003fn014"><p id="__p50" class="p p-first-last">** P &lt; 0.01</p></div><div id="t003fn015"><p id="__p51" class="p p-first-last">*** for P &lt; 0.001</p></div></div></div></div><div id="sec019" class="sec sec-last"><h3 id="sec019title">Metabonomics studies</h3><p id="__p52" class="p p-first">The <sup>1</sup>H NMR analysis indicated a metabolic difference in the blood serum samples attributed to variation in the serum lipid content between the two groups (AS vs NS). <a href="/pmc/articles/PMC4364783/figure/pone.0116212.g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0116212.g003" rid-ob="ob-pone.0116212.g003" co-legend-rid="lgnd_pone.0116212.g003"><span>Fig. 3A and 3B</span></a>, where the OPLS-DA scores plot along with the respective loadings plot in the form of a pseudo-NMR spectrum depicts these findings. Confirmation of the serum <sup>1</sup>H NMR data was obtained using UPLC-MS lipidomics on a sample subset chosen randomly from each group (n = 12 per group). The sensitivity of this metabonomic approach was demonstrated as the models predicted the sex of individuals, irrespective of group (<a href="/pmc/articles/PMC4364783/figure/pone.0116212.g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone.0116212.g003" rid-ob="ob-pone.0116212.g003" co-legend-rid="lgnd_pone.0116212.g003"><span>Fig. 3C and 3D</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone.0116212.g003" co-legend-rid="lgnd_pone.0116212.g003"><a href="/pmc/articles/PMC4364783/figure/pone.0116212.g003/" target="figure" rid-figpopup="pone.0116212.g003" rid-ob="ob-pone.0116212.g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140572973810336" class="figure"><a href="/pmc/articles/PMC4364783/figure/pone.0116212.g003/" target="figure" rid-figpopup="pone.0116212.g003" rid-ob="ob-pone.0116212.g003"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4364783_pone.0116212.g003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is pone.0116212.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4364783/bin/pone.0116212.g003.jpg"></a></div><div id="largeobj_idm140572973810336" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4364783/figure/pone.0116212.g003/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_pone.0116212.g003"><div><a class="figpopup" href="/pmc/articles/PMC4364783/figure/pone.0116212.g003/" target="figure" rid-figpopup="pone.0116212.g003" rid-ob="ob-pone.0116212.g003">Fig 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Analysis of 600 MHz <sup>1</sup>H NMR human serum baseline (pre-bar consumption) data from sensitive and control participants (A), and female and male participants (C).</strong><p id="__p53">3A. OPLS-DA scores plot demonstrating that metabolic variation is dominated by inter-group (sensitive versus control) variation; 3B. OPLS-DA regression coefficient loadings plot (in the form of pseudo-NMR spectrum) of sensitive vs. non-sensitive confirming discriminatory peaks of interest identified by analysis of the raw spectra as being strongly associated with lipids. The signal orientation indicates a higher concentration of characteristic lipid metabolites in the sensitive population; 3C. OPLS-DA scores plot demonstrating clear separation of male (red symbols) from female (black symbols) subjects; 3D. OPLS-DA regression coefficient loadings plot (in the form of pseudo-NMR spectrum) male vs female confirming discriminatory peaks of interest identified by analysis of the raw spectra. The signal orientation indicates increased creatinine in males and increased choline-containing metabolites in females. For the loadings plots in B and D, the color-coded scale reflects the significance of the correlation of each metabolite with the separation (red indicates highest significance and blue indicates no significance).</p></div></div></div><p id="__p54" class="p p-last">No significant differences were found between the baseline samples from the AS and NS individuals using <sup>1</sup>H NMR of the urine, nor were any significant differences found in the samples from the AS and NS individuals before or after aspartame or control bars.</p></div></div><div id="sec020" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec020title">Discussion</h2><p id="__p55" class="p p-first">This independent study set out to directly address the considerable anxiety surrounding aspartame consumption but found no difference in symptoms reported after aspartame and control, and no consequential differences between aspartame sensitive and non-sensitive participants; nor did consumption result in biochemical or metabolic differences. In combination, these findings assume that there is no acute adverse response to aspartame. Individuals reporting sensitivity to aspartame reported more symptoms, but after both bars equally and often during the first test session. These findings are in accord with the scientific data on aspartame [<a href="#pone.0116212.ref003" rid="pone.0116212.ref003" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_695073015" role="button" aria-expanded="false" aria-haspopup="true">3</a>,<a href="#pone.0116212.ref019" rid="pone.0116212.ref019" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">19</a>,<a href="#pone.0116212.ref031" rid="pone.0116212.ref031" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701142" role="button" aria-expanded="false" aria-haspopup="true">31</a>].</p><p id="__p56">There are a number of limitations. In order to minimise bias, participants were not monitored whilst completing rating scales, resulting in missing rating data. In addition, a small number of participants failed to complete the ratings at all. However, it is difficult to imagine a scenario where participants experiencing symptoms would leave relevant scales blank.</p><p id="__p57">Regarding metabolic parameters, sensitive subjects had significantly lower HDL and higher triglyceride levels, reflected in the metabonomic data, suggesting that this was not a type 1 error. No other biochemical or metabonomic parameters differed between the two groups of participants.</p><p id="__p58">There was a significant increase in plasma GLP-1 and reduction of plasma GIP-1 between baseline and 4 hour after both aspartame and control preparation in all study participants. GLP-1 usually rises one to four hours after nutrient intake. GIP levels are reported to peak between 15 and 45 minutes after meals, but there are no studies reporting GIP levels 4 hours after meals. The results suggest that the observed response of these incretin hormones with both the aspartame and control bar is due to the nutrients in the bar rather than aspartame.</p><p id="__p59">There was a significant reduction of both phenylalanine and tyrosine 4 hours after ingestion of both aspartame and control bars. After oral ingestion, aspartame is rapidly hydrolysed within the lumen of the gastro-intestinal (GI) tract, with a half-life in the order of minutes[<a href="#pone.0116212.ref032" rid="pone.0116212.ref032" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">32</a>] resulting in formation of methanol and the amino acids, aspartic acid and phenylalanine. Phenylalanine has a short half-life in plasma of approximately 1.7h[<a href="#pone.0116212.ref033" rid="pone.0116212.ref033" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701147" role="button" aria-expanded="false" aria-haspopup="true">33</a>] as such it was not expected that there would be any observable effects on blood phenylalanine levels under normal conditions, but the measure was undertaken so that any unusual metabolic effect should not go undetected. Methanol, whilst highly toxic, is subject to significant first pass metabolism via formaldehyde to formate. Also, it is known that formation of methanol from ingestion of aspartame is of lower magnitude than methanol from endogenous pathways and from other ingested sources, e.g. fruit juice [<a href="#pone.0116212.ref034" rid="pone.0116212.ref034" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701129" role="button" aria-expanded="false" aria-haspopup="true">34</a>–<a href="#pone.0116212.ref036" rid="pone.0116212.ref036" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">36</a>]. As expected metabonomics failed to detect methanol or significant increases in formate in blood or urine as constitutive levels would mask any change.</p><p id="__p60">It was anticipated that 48 individuals self-reporting aspartame sensitivity would be recruited within one year, but recruitment took 2.5 years despite high-level media coverage. This is exemplified by 147 individuals initially volunteering for the study before one aspartame sensitive individual participated; this likely reflects their genuine fear of aspartame consumption. Thus the achieved sample may not be representative of the population of people who believe they are aspartame sensitive, but it was impossible to recruit those most fearful.</p><p id="__p61" class="p p-last">This study looked only at acute effects and cannot exclude the possibility of chronic, cumulative effects of aspartame on biological parameters and on the psychological state[<a href="#pone.0116212.ref037" rid="pone.0116212.ref037" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701146" role="button" aria-expanded="false" aria-haspopup="true">37</a>,<a href="#pone.0116212.ref038" rid="pone.0116212.ref038" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_694701141" role="button" aria-expanded="false" aria-haspopup="true">38</a>]. Also, the dose given is smaller than the daily intake of many individuals. However, it is greater than the intake at which the people reporting aspartame sensitivity believe that they suffer symptoms[<a href="#pone.0116212.ref023" rid="pone.0116212.ref023" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">23</a>].</p></div><div id="sec021" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec021title">Conclusion</h2><p id="__p62" class="p p-first-last">Measuring psychological condition, symptoms, biochemistry and metabonomics, there was no evidence of any acute adverse responses to aspartame. This independent study gives reassurance that the acute ingestion of aspartame does not have any detectable psychological or metabolic effects in humans.</p></div><div id="sec022" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="sec022title">Supporting Information</h2><!--/article/body/sec/--><div class="sec suppmat" id="pone.0116212.s001"><h4>S1 CONSORT Checklist</h4><!--caption a9--><strong>CONSORT checklist. </strong><p id="__p63">(DOC)</p><div class="sup-box half_rhythm" id="idm140572978136384"><a href="/pmc/articles/PMC4364783/bin/pone.0116212.s001.doc" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(217K, doc)</sup></div></div><div class="sec suppmat" id="pone.0116212.s002"><h4>S1 Protocol</h4><!--caption a9--><strong>Trial Protocol. </strong><p id="__p65">(DOC)</p><div class="sup-box half_rhythm" id="idm140572973087456"><a href="/pmc/articles/PMC4364783/bin/pone.0116212.s002.doc" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(93K, doc)</sup></div></div></div><div id="idm140572973085856" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140572973085856title">Acknowledgments</h2><div class="sec"><p id="__p67">We would like to acknowledge Fraser Courts, Institute of Food Research, Norfolk, UK for Phenylalanine and Tyrosine analysis during his employment with University of Hull, UK.</p></div></div><div id="idm140572978992384" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140572978992384title">Funding Statement</h2><p>This study was supported by the Food Standards Agency, United Kingdom, T01054.</p></div><div id="idm140572984875040" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140572984875040title">Data Availability</h2><p id="__p9">All relevant data are within the paper and its Supporting Information files.</p></div><div id="idm140572975012000" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140572975012000title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref001">1. <span class="mixed-citation">Food and Drug Adminstration (2007) FDA Statement on European Aspartame Study. Silver Spring MD.</span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref002">2. <span class="mixed-citation">
Lean ME, Hankey CR (2004) <span class="ref-title">Aspartame and its effects on health</span>. <span class="ref-journal">BMJ</span>
<span class="ref-vol">329</span>: 755–756.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC520987/">PMC free article</a>]</span> [<a href="/pubmed/15459030" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Aspartame+and+its+effects+on+health&amp;author=ME+Lean&amp;author=CR+Hankey&amp;volume=329&amp;publication_year=2004&amp;pages=755-756&amp;pmid=15459030&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref003">3. <span class="mixed-citation">
Zehetner A, McLean M (1999) <span class="ref-title">Aspartame and the internet</span>. <span class="ref-journal">Lancet</span>
<span class="ref-vol">354</span>: 78
 [<a href="/pubmed/10406399" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Aspartame+and+the+internet&amp;author=A+Zehetner&amp;author=M+McLean&amp;volume=354&amp;publication_year=1999&amp;pages=78&amp;pmid=10406400&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref004">4. <span class="mixed-citation">
Camfield PR, Camfield CS, Dooley JM, Gordon K, Jollymore S, et al. (1992) <span class="ref-title">Aspartame exacerbates EEG spike-wave discharge in children with generalized absence epilepsy: a double-blind controlled study</span>. <span class="ref-journal">Neurology</span>
<span class="ref-vol">42</span>: 1000–1003.
 [<a href="/pubmed/1579221" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Aspartame+exacerbates+EEG+spike-wave+discharge+in+children+with+generalized+absence+epilepsy:+a+double-blind+controlled+study&amp;author=PR+Camfield&amp;author=CS+Camfield&amp;author=JM+Dooley&amp;author=K+Gordon&amp;author=S+Jollymore&amp;volume=42&amp;publication_year=1992&amp;pages=1000-1003&amp;pmid=1579221&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref005">5. <span class="mixed-citation">
Watts RS (1991) <span class="ref-title">Aspartame, headaches and beta blockers</span>. <span class="ref-journal">Headache</span>
<span class="ref-vol">31</span>: 181–182.
 [<a href="/pubmed/1676993" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Headache&amp;title=Aspartame,+headaches+and+beta+blockers&amp;author=RS+Watts&amp;volume=31&amp;publication_year=1991&amp;pages=181-182&amp;pmid=1676993&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref006">6. <span class="mixed-citation">
Van den Eeden SK, Koepsell TD, Longstreth WT Jr., van Belle G, Daling JR, et al. (1994) <span class="ref-title">Aspartame ingestion and headaches: a randomized crossover trial</span>. <span class="ref-journal">Neurology</span>
<span class="ref-vol">44</span>: 1787–1793.
 [<a href="/pubmed/7936222" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Aspartame+ingestion+and+headaches:+a+randomized+crossover+trial&amp;author=SK+Van+den+Eeden&amp;author=TD+Koepsell&amp;author=WT+Longstreth&amp;author=G+van+Belle&amp;author=JR+Daling&amp;volume=44&amp;publication_year=1994&amp;pages=1787-1793&amp;pmid=7936222&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref007">7. <span class="mixed-citation">
Tordoff MG, Alleva AM (1990) <span class="ref-title">Oral stimulation with aspartame increases hunger</span>. <span class="ref-journal">Physiol Behav</span>
<span class="ref-vol">47</span>: 555–559.
 [<a href="/pubmed/2359769" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Physiol+Behav&amp;title=Oral+stimulation+with+aspartame+increases+hunger&amp;author=MG+Tordoff&amp;author=AM+Alleva&amp;volume=47&amp;publication_year=1990&amp;pages=555-559&amp;pmid=2359769&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref008">8. <span class="mixed-citation">
Strathman I (1991) <span class="ref-title">Recurrent vulvovaginitis resulting from Candida species was the heavy dietary use of "artificial sweeteners"</span>. <span class="ref-journal">J Reprod Med</span>
<span class="ref-vol">36</span>: 572
 [<a href="/pubmed/1941798" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Reprod+Med&amp;title=Recurrent+vulvovaginitis+resulting+from+Candida+species+was+the+heavy+dietary+use+of+&quot;artificial+sweeteners&quot;&amp;author=I+Strathman&amp;volume=36&amp;publication_year=1991&amp;pages=572&amp;pmid=1941798&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref009">9. <span class="mixed-citation">
Schiffman SS, Buckley CE 3rd, Sampson HA, Massey EW, Baraniuk JN, et al. (1987) <span class="ref-title">Aspartame and susceptibility to headache</span>. <span class="ref-journal">N Engl J Med</span>
<span class="ref-vol">317</span>: 1181–1185.
 [<a href="/pubmed/3657889" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Aspartame+and+susceptibility+to+headache&amp;author=SS+Schiffman&amp;author=CE+Buckley&amp;author=HA+Sampson&amp;author=EW+Massey&amp;author=JN+Baraniuk&amp;volume=317&amp;publication_year=1987&amp;pages=1181-1185&amp;pmid=3657889&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref010">10. <span class="mixed-citation">
Koehler SM, Glaros A (1988) <span class="ref-title">The effect of aspartame on migraine headache</span>. <span class="ref-journal">Headache</span>
<span class="ref-vol">28</span>: 10–14.
 [<a href="/pubmed/3277925" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Headache&amp;title=The+effect+of+aspartame+on+migraine+headache&amp;author=SM+Koehler&amp;author=A+Glaros&amp;volume=28&amp;publication_year=1988&amp;pages=10-14&amp;pmid=3277925&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref011">11. <span class="mixed-citation">
Lipton RB, Newman LC, Cohen JS, Solomon S (1989) <span class="ref-title">Aspartame as a dietary trigger of headache</span>. <span class="ref-journal">Headache</span>
<span class="ref-vol">29</span>: 90–92.
 [<a href="/pubmed/2708042" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Headache&amp;title=Aspartame+as+a+dietary+trigger+of+headache&amp;author=RB+Lipton&amp;author=LC+Newman&amp;author=JS+Cohen&amp;author=S+Solomon&amp;volume=29&amp;publication_year=1989&amp;pages=90-92&amp;pmid=2708042&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref012">12. <span class="mixed-citation">
Lapierre KA, Greenblatt DJ, Goddard JE, Harmatz JS, Shader RI (1990) <span class="ref-title">The neuropsychiatric effects of aspartame in normal volunteers</span>. <span class="ref-journal">J Clin Pharmacol</span>
<span class="ref-vol">30</span>: 454–460.
 [<a href="/pubmed/2347957" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pharmacol&amp;title=The+neuropsychiatric+effects+of+aspartame+in+normal+volunteers&amp;author=KA+Lapierre&amp;author=DJ+Greenblatt&amp;author=JE+Goddard&amp;author=JS+Harmatz&amp;author=RI+Shader&amp;volume=30&amp;publication_year=1990&amp;pages=454-460&amp;pmid=2347957&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref013">13. <span class="mixed-citation">
Ryan-Harshman M, Leiter LA, Anderson GH (1987) <span class="ref-title">Phenylalanine and aspartame fail to alter feeding behavior, mood and arousal in men</span>. <span class="ref-journal">Physiol Behav</span>
<span class="ref-vol">39</span>: 247–253.
 [<a href="/pubmed/3575461" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Physiol+Behav&amp;title=Phenylalanine+and+aspartame+fail+to+alter+feeding+behavior,+mood+and+arousal+in+men&amp;author=M+Ryan-Harshman&amp;author=LA+Leiter&amp;author=GH+Anderson&amp;volume=39&amp;publication_year=1987&amp;pages=247-253&amp;pmid=3575461&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref014">14. <span class="mixed-citation">
Pivonka EE, Grunewald KK (1990) <span class="ref-title">Aspartame- or sugar-sweetened beverages: effects on mood in young women</span>. <span class="ref-journal">J Am Diet Assoc</span>
<span class="ref-vol">90</span>: 250–254.
 [<a href="/pubmed/2303661" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Diet+Assoc&amp;title=Aspartame-+or+sugar-sweetened+beverages:+effects+on+mood+in+young+women&amp;author=EE+Pivonka&amp;author=KK+Grunewald&amp;volume=90&amp;publication_year=1990&amp;pages=250-254&amp;pmid=2303661&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref015">15. <span class="mixed-citation">
Stokes AF, Belger A, Banich MT, Taylor H (1991) <span class="ref-title">Effects of acute aspartame and acute alcohol ingestion upon the cognitive performance of pilots</span>. <span class="ref-journal">Aviat Space Environ Med</span>
<span class="ref-vol">62</span>: 648–653.
 [<a href="/pubmed/1898300" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Aviat+Space+Environ+Med&amp;title=Effects+of+acute+aspartame+and+acute+alcohol+ingestion+upon+the+cognitive+performance+of+pilots&amp;author=AF+Stokes&amp;author=A+Belger&amp;author=MT+Banich&amp;author=H+Taylor&amp;volume=62&amp;publication_year=1991&amp;pages=648-653&amp;pmid=1898300&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref016">16. <span class="mixed-citation">
Stokes AF, Belger A, Banich MT, Bernadine E (1994) <span class="ref-title">Effects of alcohol and chronic aspartame ingestion upon performance in aviation relevant cognitive tasks</span>. <span class="ref-journal">Aviat Space Environ Med</span>
<span class="ref-vol">65</span>: 7–15.
 [<a href="/pubmed/8117231" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Aviat+Space+Environ+Med&amp;title=Effects+of+alcohol+and+chronic+aspartame+ingestion+upon+performance+in+aviation+relevant+cognitive+tasks&amp;author=AF+Stokes&amp;author=A+Belger&amp;author=MT+Banich&amp;author=E+Bernadine&amp;volume=65&amp;publication_year=1994&amp;pages=7-15&amp;pmid=8117231&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref017">17. <span class="mixed-citation">
Spiers PA, Sabounjian L, Reiner A, Myers DK, Wurtman J, et al. (1998) <span class="ref-title">Aspartame: neuropsychologic and neurophysiologic evaluation of acute and chronic effects</span>. <span class="ref-journal">Am J Clin Nutr</span>
<span class="ref-vol">68</span>: 531–537.
 [<a href="/pubmed/9734727" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Clin+Nutr&amp;title=Aspartame:+neuropsychologic+and+neurophysiologic+evaluation+of+acute+and+chronic+effects&amp;author=PA+Spiers&amp;author=L+Sabounjian&amp;author=A+Reiner&amp;author=DK+Myers&amp;author=J+Wurtman&amp;volume=68&amp;publication_year=1998&amp;pages=531-537&amp;pmid=9734727&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref018">18. <span class="mixed-citation">
Walton RG, Hudak R, Green-Waite RJ (1993) <span class="ref-title">Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population</span>. <span class="ref-journal">Biol Psychiatry</span>
<span class="ref-vol">34</span>: 13–17.
 [<a href="/pubmed/8373935" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biol+Psychiatry&amp;title=Adverse+reactions+to+aspartame:+double-blind+challenge+in+patients+from+a+vulnerable+population&amp;author=RG+Walton&amp;author=R+Hudak&amp;author=RJ+Green-Waite&amp;volume=34&amp;publication_year=1993&amp;pages=13-17&amp;pmid=8373935&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref019">19. <span class="mixed-citation">European Food Safety Authority (2013) Public consultation on the draft scientific opinion on the re-evaluation of aspartame (E951) as food additive.</span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref020">20. <span class="mixed-citation">
Robbins PI, Raymond L (1999) <span class="ref-title">Aspartame and symptoms of carpal tunnel syndrome</span>. <span class="ref-journal">J Occup Environ Med</span>
<span class="ref-vol">41</span>: 418
 [<a href="/pubmed/10390691" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Occup+Environ+Med&amp;title=Aspartame+and+symptoms+of+carpal+tunnel+syndrome&amp;author=PI+Robbins&amp;author=L+Raymond&amp;volume=41&amp;publication_year=1999&amp;pages=418&amp;pmid=10390691&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref021">21. <span class="mixed-citation">
Roberts HJ (1988) <span class="ref-title">Reactions attributed to aspartame containing products: 551 cases</span>. <span class="ref-journal">Journal of Applied Nutrition</span>
<span class="ref-vol">40</span>: 85–94. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Applied+Nutrition&amp;title=Reactions+attributed+to+aspartame+containing+products:+551+cases&amp;author=HJ+Roberts&amp;volume=40&amp;publication_year=1988&amp;pages=85-94&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref022">22. <span class="mixed-citation">
Roberts HJ (1996) <span class="ref-title">Aspartame as a cause of allergic reactions, including anaphylaxis</span>. <span class="ref-journal">Arch Intern Med</span>
<span class="ref-vol">156</span>: 1027–1028.
 [<a href="/pubmed/8624169" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Intern+Med&amp;title=Aspartame+as+a+cause+of+allergic+reactions,+including+anaphylaxis&amp;author=HJ+Roberts&amp;volume=156&amp;publication_year=1996&amp;pages=1027-1028&amp;pmid=8624169&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref023">23. <span class="mixed-citation">
Roberts HJ (2001) <span class="ref-title">Aspartame disease; an ignored epidemic</span>.: West Palm Beach, Florida: Sunshine Sentinel Press, Inc; 
 <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=
+Roberts+HJ++(+2001+)++Aspartame+disease;+an+ignored+epidemic+.:++West+Palm+Beach,+Florida+:++Sunshine+Sentinel+Press,+Inc+
+" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref024">24. <span class="mixed-citation">
Ferland A, Broderick TL, Nadeau A, Simard S, Martin J, et al. (2007) <span class="ref-title">Impact of fasting and postprandial state on plasma carnitine concentrations during aerobic exercise in type 2 diabetes</span>. <span class="ref-journal">Acta Diabetol</span>
<span class="ref-vol">44</span>: 114–120.
 [<a href="/pubmed/17721749" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Diabetol&amp;title=Impact+of+fasting+and+postprandial+state+on+plasma+carnitine+concentrations+during+aerobic+exercise+in+type+2+diabetes&amp;author=A+Ferland&amp;author=TL+Broderick&amp;author=A+Nadeau&amp;author=S+Simard&amp;author=J+Martin&amp;volume=44&amp;publication_year=2007&amp;pages=114-120&amp;pmid=17721749&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref025">25. <span class="mixed-citation">European Food, Safety Authority (2010) European Food Safety Authority. Report on the meeting of Aspartame with National Experts.</span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref026">26. <span class="mixed-citation">
Hertzog MA (2008) <span class="ref-title">Considerations in determining sample size for pilot studies</span>. <span class="ref-journal">Res Nurs Health</span>
<span class="ref-vol">31</span>: 180–191. 10.1002/nur.20247
 [<a href="/pubmed/18183564" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fnur.20247" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Res+Nurs+Health&amp;title=Considerations+in+determining+sample+size+for+pilot+studies&amp;author=MA+Hertzog&amp;volume=31&amp;publication_year=2008&amp;pages=180-191&amp;pmid=18183564&amp;doi=10.1002/nur.20247&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref027">27. <span class="mixed-citation">
Enck P, Benedetti F, Schedlowski M (2008) <span class="ref-title">New insights into the placebo and nocebo responses</span>. <span class="ref-journal">Neuron</span>
<span class="ref-vol">59</span>: 195–206. 10.1016/j.neuron.2008.06.030
 [<a href="/pubmed/18667148" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.neuron.2008.06.030" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuron&amp;title=New+insights+into+the+placebo+and+nocebo+responses&amp;author=P+Enck&amp;author=F+Benedetti&amp;author=M+Schedlowski&amp;volume=59&amp;publication_year=2008&amp;pages=195-206&amp;pmid=18667148&amp;doi=10.1016/j.neuron.2008.06.030&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref028">28. <span class="mixed-citation">
Cloarec O, Dumas ME, Trygg J, Craig A, Barton RH, et al. (2005) <span class="ref-title">Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies</span>. <span class="ref-journal">Anal Chem</span>
<span class="ref-vol">77</span>: 517–526.
 [<a href="/pubmed/15649048" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anal+Chem&amp;title=Evaluation+of+the+orthogonal+projection+on+latent+structure+model+limitations+caused+by+chemical+shift+variability+and+improved+visualization+of+biomarker+changes+in+1H+NMR+spectroscopic+metabonomic+studies&amp;author=O+Cloarec&amp;author=ME+Dumas&amp;author=J+Trygg&amp;author=A+Craig&amp;author=RH+Barton&amp;volume=77&amp;publication_year=2005&amp;pages=517-526&amp;pmid=15649048&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref029">29. <span class="mixed-citation">
Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G (2006) <span class="ref-title">XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification</span>. <span class="ref-journal">Anal Chem</span>
<span class="ref-vol">78</span>: 779–787.
 [<a href="/pubmed/16448051" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anal+Chem&amp;title=XCMS:+processing+mass+spectrometry+data+for+metabolite+profiling+using+nonlinear+peak+alignment,+matching,+and+identification&amp;author=CA+Smith&amp;author=EJ+Want&amp;author=G+O'Maille&amp;author=R+Abagyan&amp;author=G+Siuzdak&amp;volume=78&amp;publication_year=2006&amp;pages=779-787&amp;pmid=16448051&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref030">30. <span class="mixed-citation">
Veselkov KA, Vingara LK, Masson P, Robinette SL, Want E, et al. (2011) <span class="ref-title">Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery</span>. <span class="ref-journal">Anal Chem</span>
<span class="ref-vol">83</span>: 5864–5872. 10.1021/ac201065j
 [<a href="/pubmed/21526840" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1021%2Fac201065j" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anal+Chem&amp;title=Optimized+preprocessing+of+ultra-performance+liquid+chromatography/mass+spectrometry+urinary+metabolic+profiles+for+improved+information+recovery&amp;author=KA+Veselkov&amp;author=LK+Vingara&amp;author=P+Masson&amp;author=SL+Robinette&amp;author=E+Want&amp;volume=83&amp;publication_year=2011&amp;pages=5864-5872&amp;pmid=21526840&amp;doi=10.1021/ac201065j&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref031">31. <span class="mixed-citation">
Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, et al. (2007) <span class="ref-title">Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies</span>. <span class="ref-journal">Crit Rev Toxicol</span>
<span class="ref-vol">37</span>: 629–727.
 [<a href="/pubmed/17828671" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Rev+Toxicol&amp;title=Aspartame:+a+safety+evaluation+based+on+current+use+levels,+regulations,+and+toxicological+and+epidemiological+studies&amp;author=BA+Magnuson&amp;author=GA+Burdock&amp;author=J+Doull&amp;author=RM+Kroes&amp;author=GM+Marsh&amp;volume=37&amp;publication_year=2007&amp;pages=629-727&amp;pmid=17828671&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref032">32. <span class="mixed-citation">
Prankerd RJ, Stone HW, Sloan KB, Perrin JH (1992) <span class="ref-title">Degradation of aspartame in acidic aqueous media and its stabilization by complexation with cyclodextrins or modifed cyclodextrins</span>. <span class="ref-journal">International Journal of Pharmaceutics</span>
<span class="ref-vol">88</span>: 188–199. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=International+Journal+of+Pharmaceutics&amp;title=Degradation+of+aspartame+in+acidic+aqueous+media+and+its+stabilization+by+complexation+with+cyclodextrins+or+modifed+cyclodextrins&amp;author=RJ+Prankerd&amp;author=HW+Stone&amp;author=KB+Sloan&amp;author=JH+Perrin&amp;volume=88&amp;publication_year=1992&amp;pages=188-199&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref033">33. <span class="mixed-citation">
Filer LJ Jr., Stegink LD (1989) <span class="ref-title">Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects</span>. <span class="ref-journal">Diabetes Care</span>
<span class="ref-vol">12</span>: 67–74.
 [<a href="/pubmed/2653751" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Care&amp;title=Aspartame+metabolism+in+normal+adults,+phenylketonuric+heterozygotes,+and+diabetic+subjects&amp;author=LJ+Filer&amp;author=LD+Stegink&amp;volume=12&amp;publication_year=1989&amp;pages=67-74&amp;pmid=2653751&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref034">34. <span class="mixed-citation">
Lindinger W, Taucher J, Jordan A, Hansel A, Vogel W (1997) <span class="ref-title">Endogenous production of methanol after the consumption of fruit</span>. <span class="ref-journal">Alcohol Clin Exp Res</span>
<span class="ref-vol">21</span>: 939–943.
 [<a href="/pubmed/9267548" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Alcohol+Clin+Exp+Res&amp;title=Endogenous+production+of+methanol+after+the+consumption+of+fruit&amp;author=W+Lindinger&amp;author=J+Taucher&amp;author=A+Jordan&amp;author=A+Hansel&amp;author=W+Vogel&amp;volume=21&amp;publication_year=1997&amp;pages=939-943&amp;pmid=9267548&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref035">35. <span class="mixed-citation">
Dhareshwar SS, Stella VJ (2008) <span class="ref-title">Your prodrug releases formaldehyde: should you be concerned? No!</span>
<span class="ref-journal">J Pharm Sci</span>
<span class="ref-vol">97</span>: 4184–4193. 10.1002/jps.21319
 [<a href="/pubmed/18288723" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fjps.21319" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Sci&amp;title=Your+prodrug+releases+formaldehyde:+should+you+be+concerned?+No!&amp;author=SS+Dhareshwar&amp;author=VJ+Stella&amp;volume=97&amp;publication_year=2008&amp;pages=4184-4193&amp;pmid=18288723&amp;doi=10.1002/jps.21319&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref036">36. <span class="mixed-citation">(2011) Committee of toxicity of chemicals in food consumer products and the environment. COT statement on the chronic daily exposure to methanol. Available: <a href="http://cot.food.gov.uk/pdfs/cotstatementmethanol201102revjuly.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://cot.food.gov.uk/pdfs/cotstatementmethanol201102revjuly.pdf</a>.</span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref037">37. <span class="mixed-citation">
Jang W, Jeoung NH, Cho KH (2011) <span class="ref-title">Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-free and lipid-bound state</span>. <span class="ref-journal">Mol Cells</span>
<span class="ref-vol">31</span>: 461–470. 10.1007/s10059-011-1009-3
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3887604/">PMC free article</a>]</span> [<a href="/pubmed/21533907" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs10059-011-1009-3" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cells&amp;title=Modified+apolipoprotein+(apo)+A-I+by+artificial+sweetener+causes+severe+premature+cellular+senescence+and+atherosclerosis+with+impairment+of+functional+and+structural+properties+of+apoA-I+in+lipid-free+and+lipid-bound+state&amp;author=W+Jang&amp;author=NH+Jeoung&amp;author=KH+Cho&amp;volume=31&amp;publication_year=2011&amp;pages=461-470&amp;pmid=21533907&amp;doi=10.1007/s10059-011-1009-3&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0116212.ref038">38. <span class="mixed-citation">
Belpoggi F, Soffritti M, Padovani M, Degli Esposti D, et al. (2006) <span class="ref-title">Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed</span>. <span class="ref-journal">Ann N Y Acad Sci</span>
<span class="ref-vol">1076</span>: 559–577.
 [<a href="/pubmed/17119233" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+N+Y+Acad+Sci&amp;title=Results+of+long-term+carcinogenicity+bioassay+on+Sprague-Dawley+rats+exposed+to+aspartame+administered+in+feed&amp;author=F+Belpoggi&amp;author=M+Soffritti&amp;author=M+Padovani&amp;author=Esposti+D+Degli&amp;volume=1076&amp;publication_year=2006&amp;pages=559-577&amp;pmid=17119233&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2" style=""><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140572980798112title">Abstract</a></li><li><a href="#sec006title">Introduction</a></li><li><a href="#sec007title">Study Design</a></li><li><a href="#sec015title">Results</a></li><li><a href="#sec020title">Discussion</a></li><li><a href="#sec021title">Conclusion</a></li><li><a href="#sec022title">Supporting Information</a></li><li><a href="#idm140572973085856title">Acknowledgments</a></li><li><a href="#idm140572978992384title">Funding Statement</a></li><li><a href="#idm140572984875040title">Data Availability</a></li><li><a href="#idm140572975012000title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">PLoS ONE</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC4364783/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC4364783/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC4364783/pdf/pone.0116212.pdf">PDF (993K)</a></li> | <li><a href="#" data-citationid="PMC4364783" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4364783%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4364783%2F&amp;text=Aspartame%20Sensitivity%3F%20A%20Double%20Blind%20Randomised%20Crossover%20Study" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4364783%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="25786106" data-aiid="4364783" data-aid="4364783" data-iid="250028" data-domainid="440" data-domain="plosone" data-accid="PMC4364783" data-md5="19682a826005bfed559cd4e5d5678b94">

<div>










</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-pone.0116212.ref001" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">1. <span class="mixed-citation">Food and Drug Adminstration (2007) FDA Statement on European Aspartame Study. Silver Spring MD.</span> [<a href="#pone.0116212.ref001">Ref list</a>]</div><div id="body-link-popper-pone.0116212.ref002" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Aspartame and its effects on health.<div class="authors">Lean ME, Hankey CR</div><div class="citation">BMJ. 2004 Oct 2; 329(7469):755-6.</div><p>[<a href="/pubmed/15459030/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref002">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref003" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Aspartame and the internet.<div class="authors">Zehetner A, McLean M</div><div class="citation">Lancet. 1999 Jul 3; 354(9172):78.</div><p>[<a href="/pubmed/10406399/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref003">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref004" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Aspartame exacerbates EEG spike-wave discharge in children with generalized absence epilepsy: a double-blind controlled study.<div class="authors">Camfield PR, Camfield CS, Dooley JM, Gordon K, Jollymore S, Weaver DF</div><div class="citation">Neurology. 1992 May; 42(5):1000-3.</div><p>[<a href="/pubmed/1579221/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref004">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref008" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Recurrent vulvovaginitis resulting from Candida species was the heavy dietary use of "artificial sweeteners".<div class="authors">Strathman I</div><div class="citation">J Reprod Med. 1991 Aug; 36(8):572.</div><p>[<a href="/pubmed/1941798/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref008">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref007" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Oral stimulation with aspartame increases hunger.<div class="authors">Tordoff MG, Alleva AM</div><div class="citation">Physiol Behav. 1990 Mar; 47(3):555-9.</div><p>[<a href="/pubmed/2359769/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref007">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref006" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Aspartame ingestion and headaches: a randomized crossover trial.<div class="authors">Van den Eeden SK, Koepsell TD, Longstreth WT Jr, van Belle G, Daling JR, McKnight B</div><div class="citation">Neurology. 1994 Oct; 44(10):1787-93.</div><p>[<a href="/pubmed/7936222/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref006">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref011" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Aspartame as a dietary trigger of headache.<div class="authors">Lipton RB, Newman LC, Cohen JS, Solomon S</div><div class="citation">Headache. 1989 Feb; 29(2):90-2.</div><p>[<a href="/pubmed/2708042/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref011">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref012" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The neuropsychiatric effects of aspartame in normal volunteers.<div class="authors">Lapierre KA, Greenblatt DJ, Goddard JE, Harmatz JS, Shader RI</div><div class="citation">J Clin Pharmacol. 1990 May; 30(5):454-60.</div><p>[<a href="/pubmed/2347957/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref012">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref018" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population.<div class="authors">Walton RG, Hudak R, Green-Waite RJ</div><div class="citation">Biol Psychiatry. 1993 Jul 1-15; 34(1-2):13-7.</div><p>[<a href="/pubmed/8373935/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref018">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref019" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">19. <span class="mixed-citation">European Food Safety Authority (2013) Public consultation on the draft scientific opinion on the re-evaluation of aspartame (E951) as food additive.</span> [<a href="#pone.0116212.ref019">Ref list</a>]</div><div id="body-link-popper-pone.0116212.ref020" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Aspartame and symptoms of carpal tunnel syndrome.<div class="authors">Robbins PI, Raymond L</div><div class="citation">J Occup Environ Med. 1999 Jun; 41(6):418.</div><p>[<a href="/pubmed/10390691/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref020">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref023" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">23. <span class="mixed-citation">
Roberts HJ (2001) <span class="ref-title">Aspartame disease; an ignored epidemic</span>.: West Palm Beach, Florida: Sunshine Sentinel Press, Inc; 
 <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=
+Roberts+HJ++(+2001+)++Aspartame+disease;+an+ignored+epidemic+.:++West+Palm+Beach,+Florida+:++Sunshine+Sentinel+Press,+Inc+
+" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="#pone.0116212.ref023">Ref list</a>]</div><div id="body-link-popper-pone.0116212.ref024" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Impact of fasting and postprandial state on plasma carnitine concentrations during aerobic exercise in type 2 diabetes.<div class="authors">Ferland A, Broderick TL, Nadeau A, Simard S, Martin J, Poirier P</div><div class="citation">Acta Diabetol. 2007 Sep; 44(3):114-20.</div><p>[<a href="/pubmed/17721749/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref024">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref025" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">25. <span class="mixed-citation">European Food, Safety Authority (2010) European Food Safety Authority. Report on the meeting of Aspartame with National Experts.</span> [<a href="#pone.0116212.ref025">Ref list</a>]</div><div id="body-link-popper-pone.0116212.ref026" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Considerations in determining sample size for pilot studies.<div class="authors">Hertzog MA</div><div class="citation">Res Nurs Health. 2008 Apr; 31(2):180-91.</div><p>[<a href="/pubmed/18183564/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref026">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref027" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> New insights into the placebo and nocebo responses.<div class="authors">Enck P, Benedetti F, Schedlowski M</div><div class="citation">Neuron. 2008 Jul 31; 59(2):195-206.</div><p>[<a href="/pubmed/18667148/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref027">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref028" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies.<div class="authors">Cloarec O, Dumas ME, Trygg J, Craig A, Barton RH, Lindon JC, Nicholson JK, Holmes E</div><div class="citation">Anal Chem. 2005 Jan 15; 77(2):517-26.</div><p>[<a href="/pubmed/15649048/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref028">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref029" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification.<div class="authors">Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G</div><div class="citation">Anal Chem. 2006 Feb 1; 78(3):779-87.</div><p>[<a href="/pubmed/16448051/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref029">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref030" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery.<div class="authors">Veselkov KA, Vingara LK, Masson P, Robinette SL, Want E, Li JV, Barton RH, Boursier-Neyret C, Walther B, Ebbels TM, Pelczer I, Holmes E, Lindon JC, Nicholson JK</div><div class="citation">Anal Chem. 2011 Aug 1; 83(15):5864-72.</div><p>[<a href="/pubmed/21526840/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref030">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref031" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.<div class="authors">Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, Pariza MW, Spencer PS, Waddell WJ, Walker R, Williams GM</div><div class="citation">Crit Rev Toxicol. 2007; 37(8):629-727.</div><p>[<a href="/pubmed/17828671/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref031">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref032" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">32. <span class="mixed-citation">
Prankerd RJ, Stone HW, Sloan KB, Perrin JH (1992) <span class="ref-title">Degradation of aspartame in acidic aqueous media and its stabilization by complexation with cyclodextrins or modifed cyclodextrins</span>. <span class="ref-journal">International Journal of Pharmaceutics</span>
<span class="ref-vol">88</span>: 188–199. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=International+Journal+of+Pharmaceutics&amp;title=Degradation+of+aspartame+in+acidic+aqueous+media+and+its+stabilization+by+complexation+with+cyclodextrins+or+modifed+cyclodextrins&amp;author=RJ+Prankerd&amp;author=HW+Stone&amp;author=KB+Sloan&amp;author=JH+Perrin&amp;volume=88&amp;publication_year=1992&amp;pages=188-199&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="#pone.0116212.ref032">Ref list</a>]</div><div id="body-link-popper-pone.0116212.ref033" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects.<div class="authors">Filer LJ Jr, Stegink LD</div><div class="citation">Diabetes Care. 1989 Jan; 12(1):67-74.</div><p>[<a href="/pubmed/2653751/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref033">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref034" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Endogenous production of methanol after the consumption of fruit.<div class="authors">Lindinger W, Taucher J, Jordan A, Hansel A, Vogel W</div><div class="citation">Alcohol Clin Exp Res. 1997 Aug; 21(5):939-43.</div><p>[<a href="/pubmed/9267548/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref034">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref036" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">36. <span class="mixed-citation">(2011) Committee of toxicity of chemicals in food consumer products and the environment. COT statement on the chronic daily exposure to methanol. Available: <a href="http://cot.food.gov.uk/pdfs/cotstatementmethanol201102revjuly.pdf" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://cot.food.gov.uk/pdfs/cotstatementmethanol201102revjuly.pdf</a>.</span> [<a href="#pone.0116212.ref036">Ref list</a>]</div><div id="body-link-popper-pone.0116212.ref037" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-free and lipid-bound state.<div class="authors">Jang W, Jeoung NH, Cho KH</div><div class="citation">Mol Cells. 2011 May; 31(5):461-70.</div><p>[<a href="/pubmed/21533907/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref037">Ref list</a>]</p></div><div id="body-link-popper-pone.0116212.ref038" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed.<div class="authors">Belpoggi F, Soffritti M, Padovani M, Degli Esposti D, Lauriola M, Minardi F</div><div class="citation">Ann N Y Acad Sci. 2006 Sep; 1076():559-77.</div><p>[<a href="/pubmed/17119233/" ref="reftype=pubmed&amp;article-id=4364783&amp;issue-id=250028&amp;journal-id=440&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#pone.0116212.ref038">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 64px; left: 459px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=plosone&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC4364783/&amp;amp;ncbi_app=pmc" /&gt;</noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- 95B63906E70AD421_0000SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></htm
